Wound problems and infections after major joint arthroplasty : national survey results from primary and secondary care in the UK.
4 affiliations
- 1Centre for Hip Surgery, Wrightington Hospital, Wigan, UK.
- 2Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, Bristol, UK.
- 3Northumbria Healthcare NHS Foundation Trust, Hexham General Hospital, Hexham, UK.
- 4National Institute for Health and Care Research (NIHR), Bristol Biomedical Research Centre, Bristol, UK.
Abstract
Aims
Early postoperative wound problems following major joint arthroplasty (MJA) are common, yet comprehensive guidelines for superficial surgical site infections (SSIs) are lacking. This study aimed to explore healthcare professionals' views and management strategies for early wound problems after MJA.Methods
A national cross-sectional online survey was distributed to orthopaedic surgeons, microbiologists, general practitioners, physiotherapists, and nursing staff involved in MJA care. The survey explored perceptions of wound problems, along with diagnostic and management approaches, and sought to identify any evidence gaps. Results were reported with descriptive statistics.Results
Of 111 respondents (51% orthopaedic surgeons), 90% were involved in managing early MJA wound problems. Most (94.6%) considered early wound problems serious. Skin reactions (32.4%) and superficial wound infections (28.8%) were the most frequently cited causes. Respondents generally believed superficial infections could not be clinically distinguished from deep infections, but could be managed with oral antibiotics in primary care. However, a need for further evidence was expressed, particularly regarding diagnostic utility, intervention thresholds, and clear guidelines to differentiate superficial from deep infections. Common superficial infection signs included red skin and localized swelling, while deep infections were thought to present with fever and deep pain.Conclusion
Healthcare professionals recognize the seriousness of early postoperative wound problems, frequently encountering skin reactions and superficial SSIs. While superficial infections are often managed nonoperatively, there is a clear demand for high-level evidence and comprehensive guidelines to improve differentiation and management. This should ultimately enhance patient outcomes, reduce the time to correct diagnosis and management, and limit the need for unnecessary treatments and associated complications.
Related
- Estimation of Antimicrobial-Resistant Mycoplasma genitalium Infections in People Aged 14–59 Years: Results From the National Health and Nutrition Examination Survey, United States, 2017–2018
- COPD/OSA phenotypes and inpatient outcome patterns among primary total hip arthroplasty hospitalizations: a national inpatient sample study, 2016–2022
- Outcomes of hemophilia A in children under primary and secondary prophylaxis: results from the HEMFIL Cohort Study
- Impact of diabetic kidney disease on in-hospital complications and healthcare utilization following primary shoulder arthroplasty: a national database analysis.
- Assay Performance and Quantification Limits in Perioperative Serum Cytokine Measurement After Total Hip Arthroplasty: A Secondary Laboratory Analysis
BibTeX
@article{lamb2026wound,
title = {{Wound problems and infections after major joint arthroplasty : national survey results from primary and secondary care in the UK.}},
author = {Jonathan Nicholas Lamb and Timothy G Petheram and Erik Lenguerrand and Michael R Whitehouse and Andrew J Moore},
journal = {Bone \& joint open},
year = {2026},
month = oct,
doi = {10.1302/2633-1462.710.bjo-2026-0080.r1},
url = {https://europepmc.org/article/MED/42914124},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Wound problems and infections after major joint arthroplasty : national survey results from primary and secondary care in the UK.
AU - Jonathan Nicholas Lamb
AU - Timothy G Petheram
AU - Erik Lenguerrand
AU - Michael R Whitehouse
AU - Andrew J Moore
PY - 2026
DA - 2026/10/23
JO - Bone & joint open
DO - 10.1302/2633-1462.710.bjo-2026-0080.r1
UR - https://europepmc.org/article/MED/42914124
AB - Aims Early postoperative wound problems following major joint arthroplasty (MJA) are common, yet comprehensive guidelines for superficial surgical site infections (SSIs) are lacking. This study aimed to explore healthcare professionals' views and management strategies for early wound problems after MJA.Methods A national cross-sectional online survey was distributed to orthopaedic surgeons, microbiologists, general practitioners, physiotherapists, and nursing staff involved in MJA care. The survey explored perceptions of wound problems, along with diagnostic and management approaches, and sought to identify any evidence gaps. Results were reported with descriptive statistics.Results Of 111 respondents (51% orthopaedic surgeons), 90% were involved in managing early MJA wound problems. Most (94.6%) considered early wound problems serious. Skin reactions (32.4%) and superficial wound infections (28.8%) were the most frequently cited causes. Respondents generally believed superficial infections could not be clinically distinguished from deep infections, but could be managed with oral antibiotics in primary care. However, a need for further evidence was expressed, particularly regarding diagnostic utility, intervention thresholds, and clear guidelines to differentiate superficial from deep infections. Common superficial infection signs included red skin and localized swelling, while deep infections were thought to present with fever and deep pain.Conclusion Healthcare professionals recognize the seriousness of early postoperative wound problems, frequently encountering skin reactions and superficial SSIs. While superficial infections are often managed nonoperatively, there is a clear demand for high-level evidence and comprehensive guidelines to improve differentiation and management. This should ultimately enhance patient outcomes, reduce the time to correct diagnosis and management, and limit the need for unnecessary treatments and associated complications.
SN - 2633-1462
ER -